These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 24713244
21. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy. Abdelrahman AE, Fathy A, Elsebai EA, Nawar N, Etman WM. Ann Diagn Pathol; 2018 Aug; 35():27-37. PubMed ID: 30072015 [Abstract] [Full Text] [Related]
22. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. Vang R, Hannibal CG, Junge J, Frederiksen K, Kjaer SK, Kurman RJ. Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817 [Abstract] [Full Text] [Related]
23. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Djordjevic B, Malpica A. Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998 [Abstract] [Full Text] [Related]
24. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer]. Hu CJ, Zhang F, Chen YJ, Sun XM, Zheng JF. Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700 [Abstract] [Full Text] [Related]
25. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma. Yang G, He W, Cai M, Luo F, Kung H, Guan X, Zeng Y, Xie D. Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696 [Abstract] [Full Text] [Related]
26. [Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery]. Zhu X, Ying LS, Xu SH, Zhu CH, Xie JB. Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):666-70. PubMed ID: 21176531 [Abstract] [Full Text] [Related]
27. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype. Zhao H, Tang H, Xiao Q, He M, Zhao L, Fu Y, Wu H, Yu Z, Jiang Q, Yan Y, Jin F, Wei M. Mol Med Rep; 2016 Dec; 14(6):5261-5270. PubMed ID: 27779682 [Abstract] [Full Text] [Related]
28. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B. Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671 [Abstract] [Full Text] [Related]
29. [Expression of THY1 gene in epithelial ovarian cancer]. Zeng LQ, Peng ZL, Duan ZL. Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):118-20. PubMed ID: 19538887 [Abstract] [Full Text] [Related]
30. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, López-Basave HN, Gómora MJ, Carlón E, Cárdenas S, Silva-Ayala R, Almaraz M, Méndez C. J Ovarian Res; 2016 Jul 07; 9(1):41. PubMed ID: 27388275 [Abstract] [Full Text] [Related]
32. The potential prognostic value of cathepsin D protein in serous ovarian cancer. Chai Y, Wu W, Zhou C, Zhou J. Arch Gynecol Obstet; 2012 Aug 07; 286(2):465-71. PubMed ID: 22476353 [Abstract] [Full Text] [Related]
33. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women]. Tang L, Zheng M, Xiong Y, Ding H, Liu FY. Ai Zheng; 2008 Sep 07; 27(9):951-5. PubMed ID: 18799034 [Abstract] [Full Text] [Related]
34. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS. Kalogeraki A, Tamiolakis D, Matalliotaki C, Karvela-Kalogeraki I, Karvelas-Kalogerakis M, Segredakis J, Sinatkas V, Matalliotakis I. Rev Med Chir Soc Med Nat Iasi; 2015 Sep 07; 119(2):454-60. PubMed ID: 26204652 [Abstract] [Full Text] [Related]
35. [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma]. Wan T, Liu JH, Zheng LM, Cai MY, Ding T. Ai Zheng; 2009 Mar 07; 28(3):323-7. PubMed ID: 19619451 [Abstract] [Full Text] [Related]
36. Expression of p16, p53, CD24, EpCAM and calretinin in serous borderline tumors of the ovary. Aktaş IY, Buğdayci M, Usubütün A. Turk Patoloji Derg; 2012 Mar 07; 28(3):220-30. PubMed ID: 23011824 [Abstract] [Full Text] [Related]
37. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G. Gynecol Oncol; 2005 May 07; 97(2):379-86. PubMed ID: 15863133 [Abstract] [Full Text] [Related]
38. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N, Bozkurt KK, Başpınar Ş, Koçer M, Eroğlu HE, Akdeniz R, Akçil M. Pathol Res Pract; 2015 Oct 07; 211(10):740-7. PubMed ID: 26298632 [Abstract] [Full Text] [Related]